rs35087113

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000575282.5(SGSH):​n.923T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,578,206 control chromosomes in the GnomAD database, including 98,611 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8173 hom., cov: 32)
Exomes 𝑓: 0.35 ( 90438 hom. )

Consequence

SGSH
ENST00000575282.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.09

Publications

5 publications found
Variant links:
Genes affected
SGSH (HGNC:10818): (N-sulfoglucosamine sulfohydrolase) This gene encodes the enzyme sulfamidase; one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with the lysosomal storage disease mucopolysaccaridosis IIIA, also known as Sanfilippo syndrome A, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jun 2017]
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-80213921-A-G is Benign according to our data. Variant chr17-80213921-A-G is described in ClinVar as Benign. ClinVar VariationId is 255517.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SGSHNM_000199.5 linkc.664-36T>C intron_variant Intron 5 of 7 ENST00000326317.11 NP_000190.1 P51688

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SGSHENST00000326317.11 linkc.664-36T>C intron_variant Intron 5 of 7 1 NM_000199.5 ENSP00000314606.6 P51688

Frequencies

GnomAD3 genomes
AF:
0.319
AC:
48297
AN:
151552
Hom.:
8156
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.195
Gnomad AMI
AF:
0.199
Gnomad AMR
AF:
0.459
Gnomad ASJ
AF:
0.358
Gnomad EAS
AF:
0.399
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.356
Gnomad MID
AF:
0.331
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.352
GnomAD2 exomes
AF:
0.382
AC:
80792
AN:
211418
AF XY:
0.378
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.546
Gnomad ASJ exome
AF:
0.361
Gnomad EAS exome
AF:
0.425
Gnomad FIN exome
AF:
0.380
Gnomad NFE exome
AF:
0.344
Gnomad OTH exome
AF:
0.373
GnomAD4 exome
AF:
0.352
AC:
502464
AN:
1426538
Hom.:
90438
Cov.:
27
AF XY:
0.354
AC XY:
251253
AN XY:
709424
show subpopulations
African (AFR)
AF:
0.185
AC:
6137
AN:
33180
American (AMR)
AF:
0.537
AC:
22161
AN:
41298
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
9208
AN:
25606
East Asian (EAS)
AF:
0.341
AC:
13288
AN:
39016
South Asian (SAS)
AF:
0.405
AC:
33766
AN:
83446
European-Finnish (FIN)
AF:
0.370
AC:
16148
AN:
43642
Middle Eastern (MID)
AF:
0.354
AC:
2023
AN:
5712
European-Non Finnish (NFE)
AF:
0.346
AC:
378644
AN:
1095248
Other (OTH)
AF:
0.355
AC:
21089
AN:
59390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17920
35840
53761
71681
89601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12146
24292
36438
48584
60730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.319
AC:
48343
AN:
151668
Hom.:
8173
Cov.:
32
AF XY:
0.322
AC XY:
23867
AN XY:
74102
show subpopulations
African (AFR)
AF:
0.195
AC:
8085
AN:
41438
American (AMR)
AF:
0.460
AC:
7000
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.358
AC:
1237
AN:
3456
East Asian (EAS)
AF:
0.399
AC:
2045
AN:
5120
South Asian (SAS)
AF:
0.410
AC:
1973
AN:
4808
European-Finnish (FIN)
AF:
0.356
AC:
3739
AN:
10516
Middle Eastern (MID)
AF:
0.345
AC:
100
AN:
290
European-Non Finnish (NFE)
AF:
0.343
AC:
23242
AN:
67808
Other (OTH)
AF:
0.353
AC:
741
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1660
3320
4981
6641
8301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
1599
Bravo
AF:
0.324
Asia WGS
AF:
0.394
AC:
1369
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mucopolysaccharidosis, MPS-III-A Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 28, 2017
Counsyl
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.13
DANN
Benign
0.37
PhyloP100
-3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35087113; hg19: chr17-78187720; COSMIC: COSV58338902; COSMIC: COSV58338902; API